Patents of Jan Tavernier

IMMUNOSTIMULATORY ADJUVANTS

Patent application(s)

WO2022011005 ( 13 January 2022 )

COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES

Patent application(s)

WO2020257412 ( 24 December 2020 )

FMS-like tyrosine kinase 3 ligand (FLT3L)-Based chimeric proteins

Patent application(s)

WO2020198659 ( 01 October 2020 )

MODULATION OF DENDRITIC CELL LINEAGES

Patent application(s)

WO2020097350 ( 14 May 2020 )

FIBROBLAST BINDING AGENTS AND USE THEREOF

Patent application(s)

WO2019152979 ( 08 August 2019 )

THERAPEUTIC TARGETING OF NON-CELLULAR ANTIGENS

Patent application(s)

WO2017194782 ( 16 November 2017 )

TARGETED MUTANT INTERFERON-β USES THEREOF

Patent application(s)

WO2017194783 ( 16 November 2017 )

Granted patent(s)

EP3454887 ( 20 January 2021 )

IMMUNE-CELL TARGETED BISPECIFIC CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2018146074 ( 16 August 2018 )

Granted patent(s)

US11246911 ( 15 February 2022 )

TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF

Patent application(s)

WO2018077893 ( 03 May 2018 )

Granted patent(s)

EP3529264 ( 09 March 2022 )

TARGETED THERAPEUTIC AGENTS AND USES THEREOF

Patent application(s)

WO2017134302 ( 10 August 2017 )

Granted patent(s)

EP3411398 ( 03 April 2024 )

TARGETED CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2018141964 ( 09 August 2018 )

BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2017077382 ( 11 May 2017 )

Granted patent(s)

EP3371311 ( 21 July 2021 )

Anti-cancer therapy using a leptin antagonist and an iNKT-cell activator

Patent application(s)

WO2017207040 ( 07 December 2017 )

CD20 BINDING AGENTS AND USES THEREOF

Patent application(s)

WO2017153345 ( 14 September 2017 )

CD20 BINDING AGENTS

Patent application(s)

WO2017153402 ( 14 September 2017 )

Granted patent(s)

EP3426278 ( 03 January 2024 )

CLEC9A BINDING AGENTS AND USE THEREOF

Patent application(s)

WO2017134301 ( 10 August 2017 )

Granted patent(s)

EP3411065 ( 31 March 2021 )

CD8 BINDING AGENTS

Patent application(s)

WO2017134306 ( 10 August 2017 )

Granted patent(s)

US11236166 ( 01 February 2022 )

BISPECIFIC SIGNALING AGENT AND USES THEREOF

Patent application(s)

WO2017134305 ( 10 August 2017 )

VIRAL PARTICLE BASED SMALL MOLECULE-PROTEIN INTERACTION TRAP

Patent application(s)

WO2016150992 ( 29 September 2016 )

Granted patent(s)

EP3274722 ( 31 August 2022 )

TARGETING OF CYTOKINE ANTAGONISTS

Patent application(s)

WO2015007520 ( 22 January 2015 )

Granted patent(s)

EP3022230 ( 06 November 2019 )

FUSOKINES INVOLVING CYTOKINES WITH STRONGLY REDUCED RECEPTOR BINDING AFFINITIES

Patent application(s)

WO2015007536 ( 19 March 2015 )

Granted patent(s)

EP3299466 ( 11 September 2019 )

TARGETED MODIFIED TNF FAMILY MEMBERS

Patent application(s)

WO2015007903 ( 22 January 2015 )

Granted patent(s)

EP3021865 ( 13 June 2018 )

TARGETED MODIFIED IL-1 FAMILY MEMBERS

Patent application(s)

WO2015007542 ( 22 January 2015 )

Granted patent(s)

EP3022226 ( 05 December 2018 )

TARGETED MUTANT ALPHA-HELICAL BUNDLE CYTOKINES

Patent application(s)

WO2013107791 ( 25 July 2013 )

Granted patent(s)

EP2804877 ( 22 August 2018 )

Viral particle based protein-protein interaction trap

Patent application(s)

WO2013174999 ( 28 November 2013 )

Granted patent(s)

US11237174 ( 01 February 2022 )

Membrane span-kinase fusion protein and the uses thereof

Patent application(s)

WO2013131957 ( 12 September 2013 )

Granted patent(s)

EP2823044 ( 06 December 2017 )

KINASE SUBSTRATE SENSOR

Patent application(s)

WO2012117031 ( 07 September 2012 )

Granted patent(s)

EP2681319 ( 14 December 2016 )

The use of topoisomerase type I inhibitors to treat viral infections

Patent application(s)

WO2010020676 ( 25 February 2010 )